🇺🇸 FDA
Patent

US 8603543

Mesocellular oxide foams as hemostatic compositions and methods of use

granted A61KA61K9/0014A61K9/122

Quick answer

US patent 8603543 (Mesocellular oxide foams as hemostatic compositions and methods of use) held by The Regents of the University of California expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K9/0014, A61K9/122, A61P, A61P7/04